Marta Borghi
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Modeling hepatitis D virus kinetics during bulevirtide monotherapy: challenges and solutions.
Journal: ArXiv
Published: June 12, 2026
Mathematical modeling of HDV RNA, HBsAg, and ALT kinetics in patients with compensated cirrhosis: Insights from 96 Weeks of bulevirtide monotherapy.
Journal: Antiviral research
Published: May 20, 2026
HDV RNA Undetectability Rates During Bulevirtide Monotherapy in Patients With Chronic Hepatitis Delta May Be Assay Dependent.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: April 09, 2026
Fate of hepatitis D virus-specific CD8+ T cells during bulevirtide monotherapy in patients with chronic hepatitis delta☆.
Journal: JHEP reports : innovation in hepatology
Published: January 05, 2026
Declining but persistent hepatocellular cancer risk beyond 10 years of entecavir or tenofovir in chronic hepatitis B: Results of the PAGE-B cohort.
Journal: Journal of hepatology
Published: October 19, 2025
Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-world.
Journal: JHEP reports : innovation in hepatology
Published: July 30, 2024
HBsAg Isoforms as Innovative Biomarkers in Predicting Virological Response to Bulevirtide in Patients With Chronic Hepatitis D.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: May 31, 2024
Comparing methods for plasma HDV RNA quantification in bulevirtide-treated and untreated patients with HDV.
Journal: JHEP reports : innovation in hepatology
Published: April 23, 2024
Sodium taurocholate cotransporting polypeptide (NTCP) polymorphisms may influence HDV RNA load and early response to bulevirtide.
Journal: Journal of hepatology
Published: September 17, 2023
A new clinical and prognostic characterization of the patterns of decompensation of cirrhosis.
Journal: Journal of hepatology
Published: July 26, 2023
Modelling HDV kinetics under the entry inhibitor bulevirtide suggests the existence of two HDV-infected cell populations.
Journal: JHEP reports : innovation in hepatology
Published: March 17, 2023
Quantification of serum HDV RNA by Robogene 2.0 in HDV patients is significantly influenced by the extraction methods.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: March 10, 2023
Last Updated: 09/26/2026